πŸ‡ΊπŸ‡Έ FDA
Patent

US 11851445

Compounds and uses thereof

granted A61KA61K47/545A61K47/55

Quick answer

US patent 11851445 (Compounds and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/545, A61K47/55, A61P, A61P31/12